Friedrich, Maximilian
Son, Hyeck-Soo
Hassel, Oliver
Teich, Lilly
Augustin, Victor Aristide
Khoramnia, Ramin
Auffarth, Gerd Uwe
Yildirim, Timur Mert
Funding for this research was provided by:
Medizinische Fakultät Heidelberg der Universität Heidelberg
Article History
Received: 15 June 2024
Accepted: 11 July 2024
First Online: 22 July 2024
Declarations
:
: This study solely involves laboratory analyses of IOL explants. No additional procedures on humans or animals were performed. The local Ethics Committee of the University of Heidelberg approved this study under the reference number: S-372/2012. All patients gave written informed consent on the use of their anonymized data for scientific purposes. The study was performed in conformance with the tenets of the Declaration of Helsinki and adheres to all German federal and state laws.
: Not applicable.
: V.A.A. reports research grant from Kowa Co., Ltd. R.K. report grants, personal fees, and nonfinancial support from Johnson & Johnson Vision, Alcon Laboratories, Hoya Corp., Kowa Co., Ltd., Teleon, Physiol S.A., Sifi Medtech Srl, and Rayner Intraocular Lenses Ltd.; grants and personal fees from Oculus Optikgeräte GmbH, Carl Zeiss Meditec AG, Heidelberg Engineering and Ophtec BV; and grants from Acufocus, Inc., outside the submitted work. G.U.A. reports lecture fees and research grants from Johnson & Johnson Vision, Alcon Laboratories, Carl Zeiss Meditec AG, Hoya Corp., Kowa Co., Ltd., Oculentis GmbH/Teleon, Rayner Intraocular Lenses Ltd., Santen, Sifi Medtech Srl, and Biotech. T.M.Y. reports lecture fees from Alcon Laboratories, Johnson & Johnson Vision and Hoya Corp. and nonfinancial support from Johnson & Johnson Vision. For the remaining authors, no financial disclosures were declared.